September 19th, 2012
An Ad That Doesn’t Tell the Entire Story — Part 2: Niaspan
Harlan M. Krumholz, MD, SM
A print ad for Niaspan focuses only on how it raises HDL-cholesterol levels, with no mention of the lack of benefit in improving outcomes.
December 6th, 2010
Senate Report Exposes Abbott’s Ties to Mark Midei
Larry Husten, PHD
A U.S. Senate report exposes new information about the relationship between Abbott Laboratories and Mark Midei, the interventional cardiologist who has been accused of implanting hundreds of unnecessary stents at St. Joseph Medical Center in Maryland. News stories on the report appear in today’s Baltimore Sun, New York Times, and Wall Street Journal. While still working at St. […]
NEJM Journal Watch — Recent Cardiology Articles- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?